Lifecore Biomedical Inc. (NASDAQ: LFCR)
$7.3200
+0.3400 ( +2.52% ) 90.3K
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Market Data
Open
$7.3200
Previous close
$6.9800
Volume
90.3K
Market cap
$213.22M
Day range
$6.9650 - $7.4550
52 week range
$3.6793 - $8.9000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 53 | Nov 21, 2024 |
8-k | 8K-related | 13 | Nov 08, 2024 |
4 | Insider transactions | 1 | Oct 29, 2024 |
4 | Insider transactions | 1 | Oct 07, 2024 |
4 | Insider transactions | 1 | Oct 07, 2024 |
8-k | 8K-related | 48 | Oct 04, 2024 |
10-q | Quarterly Reports | 90 | Oct 04, 2024 |
8-k | 8K-related | 13 | Sep 23, 2024 |
def | Proxies and info statements | 22 | Sep 23, 2024 |
4/a | Other | 1 | Sep 16, 2024 |